NCT00205322View on ClinicalTrials.gov

Oxaliplatin, 5-FU and Leucovorin in Combination With Oral Capecitabine for Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Metastatic Colorectal Cancer
Interventions
DRUG

chemotherapy (capecitabine, oxaliplatin, 5-FU, leucovorin)

Trial Locations (1)

53792

University of Wisconsin, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT00205322 - Oxaliplatin, 5-FU and Leucovorin in Combination With Oral Capecitabine for Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter